(Total Views: 834)
Posted On: 07/29/2020 9:54:45 PM
Post# of 153890
A repost
My pessimistic take for CC tomorrow is a lot of talk about Baylor study. Pep talk about more enrollees in S/C trial. Discussion of safety review board and finally a projected short turn around date for efficacy analysis, like next Tuesday.
My optimistic take is the first three and finally a smiling Nader says we have the analysis completed and the efficacy is excellent. We are submitting to FDA with a request for approval for unmet need.
My pessimistic take for CC tomorrow is a lot of talk about Baylor study. Pep talk about more enrollees in S/C trial. Discussion of safety review board and finally a projected short turn around date for efficacy analysis, like next Tuesday.
My optimistic take is the first three and finally a smiling Nader says we have the analysis completed and the efficacy is excellent. We are submitting to FDA with a request for approval for unmet need.
(1)
(0)
